For patent applications filed on or after July 1, 2022, that disclose nucleic acid and/or amino acid sequences falling within the definition in 37 CFR 1.831(b), there are specific requirements for presenting these sequences. According to MPEP 2412.06: “37 CFR 1.831(a) requires conformance to the requirements of 37 CFR 1.832 through 37 CFR 1.834 with…

Read More